Related Experiment Video

Updated: Jun 20, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Recent development in carbohydrate-based cancer vaccines

Zhongwu Guo1, Qianli Wang

  • 1Department of Chemistry, Wayne State University, 5101 Cass Avenue, Detroit, MI 48202, USA. zwguo@chem.wayne.edu

Current Opinion in Chemical Biology
|September 22, 2009
PubMed

Insights

Tumor-associated carbohydrate antigens (TACAs) are key cancer markers but often fail to trigger immune responses. Researchers are developing TACA conjugates to enhance immunogenicity for effective cancer vaccines and immunotherapies.

Area of Science:

  • Oncology
  • Immunology
  • Glycobiology

Background:

  • Tumor-associated carbohydrate antigens (TACAs) are cell surface markers crucial for cancer vaccine development.
  • Most TACAs exhibit poor immunogenicity and induce immune tolerance, hindering T cell-mediated anti-cancer immunity.

Purpose of the Study:

  • To review strategies for enhancing TACA immunogenicity for improved cancer vaccines and immunotherapies.
  • To explore novel TACA conjugate vaccine designs and modifications.

Main Methods:

  • Covalent coupling of TACAs to carrier molecules to create clustered or multi-epitopic vaccines.
  • Development of multi-component glycoconjugate vaccines by linking TACAs to T cell peptide and immunostimulant epitopes.
  • Utilizing chemically modified TACAs combined with metabolic engineering of cancer cells.

Main Results:

  • Constructed TACA conjugates demonstrate improved immunogenicity compared to native TACAs.
  • Multi-component vaccines offer a promising approach to elicit robust T cell responses against cancer.
  • Chemically modified TACAs combined with metabolic engineering show potential for enhanced therapeutic effects.

Conclusions:

  • Strategies for constructing TACA conjugates are vital for overcoming immunotolerance and poor immunogenicity.
  • Advanced vaccine designs, including multi-component and modified TACA approaches, hold significant promise for cancer immunotherapy.
  • Further research into TACA-based vaccines is essential for developing effective cancer treatments.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...